Related references
Note: Only part of the references are listed.Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease A PET Study
Aline Delva et al.
NEUROLOGY (2022)
Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET
Katrine B. Andersen et al.
NUCLEAR MEDICINE AND BIOLOGY (2022)
Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer's disease: A tracer kinetic modeling study
Ming-Kai Chen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)
Reduced Synaptic Density in Patients with Lewy Body Dementia: An [11C]UCB-J PET Imaging Study
Katrine B. Andersen et al.
MOVEMENT DISORDERS (2021)
Synaptic Density and Neuronal Metabolic Function Measured by Positron Emission Tomography in the Unilateral 6-OHDA Rat Model of Parkinson's Disease
Nakul Ravi Raval et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2021)
Validation of Parametric Methods for [11C]UCB-J PET Imaging Using Subcortical White Matter as Reference Tissue
Nathalie Mertens et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
Assessment of a white matter reference region for 11C-UCB-J PET quantification
Samantha Rossano et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)
Preclinical PET Studies of [11C]UCB-J Binding in Minipig Brain
Majken Borup Thomsen et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
11C-UCB-J synaptic PET and multimodal imaging in dementia with Lewy bodies
Nicolas Nicastro et al.
EUROPEAN JOURNAL OF HYBRID IMAGING (2020)
Neuroimaging in Lewy body dementia
Tayyabah Yousaf et al.
JOURNAL OF NEUROLOGY (2019)
Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue
Michel Koole et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans
Sjoerd J. Finnema et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts
Usman Saeed et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
Nabeel B. Nabulsi et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Imaging synaptic density in the living human brain
Sjoerd J. Finnema et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging
Laura K. Teune et al.
NEUROIMAGE-CLINICAL (2014)
Brain energy metabolism and blood flow differences in healthy aging
Joel Aanerud et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Irene Litvan et al.
MOVEMENT DISORDERS (2012)
Donepezil- and scopolamine-induced rCMRglu changes assessed by PET in conscious rhesus monkeys
Makoto Asai et al.
ANNALS OF NUCLEAR MEDICINE (2009)
Cortical Hypometabolism Assessed by a Metabolic Ratio in Parkinson's Disease Primarily Reflects Cognitive Deterioration-[18F]FDG-PET
Inga Liepelt et al.
MOVEMENT DISORDERS (2009)
Distinct Patterns of Regional Cerebral Glucose Metabolism in Parkinson's Disease with and without Mild Cognitive Impairment
Yoshiyuki Hosokai et al.
MOVEMENT DISORDERS (2009)
Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease
Per Borghammer et al.
NEUROIMAGE (2009)
The neuropathological basis for depression in Parkinson's disease
Pasquale G. Frisina et al.
PARKINSONISM & RELATED DISORDERS (2009)
Cambios de la perfusión cerebral en la enfermedad de Parkinson: relación con la duración de los síntomas
M. Kapitán et al.
Revista Espanola de Medicina Nuclear (2009)
Metabolic brain networks in neurodegenerative disorders: a functional imaging approach
David Eidelberg
TRENDS IN NEUROSCIENCES (2009)
Design and implementation of an automated partial volume correction in PET: Application to dopamine receptor quantification in the normal human striatum
Olivier G. Rousset et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease
C. Huang et al.
NEUROLOGY (2008)
Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility
Yilong Ma et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies
Michael L. Kramer et al.
JOURNAL OF NEUROSCIENCE (2007)
Metabolic brain networks associated with cognitive function in Parkinson's disease
Chaorui Huang et al.
NEUROIMAGE (2007)
Dementia in Parkinson disease - Functional imaging of cholinergic and dopaminergic pathways
R Hilker et al.
NEUROLOGY (2005)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases
C Zarow et al.
ARCHIVES OF NEUROLOGY (2003)
Share Paper
